Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Am J Physiol Regul Integr Comp Physiol ; 292(4): R1542-9, 2007 Apr.
Article in English | MEDLINE | ID: mdl-17158270

ABSTRACT

The present study tested the effect of ketamine on the fetal reflex responses of late-gestation sheep to brachiocephalic occlusion (BCO), a stimulus that mimics the reduction in cerebral blood flow that results from severe fetal hypotension. Ketamine, a dissociative anesthetic and known noncompetitive antagonist of N-methyl D-aspartate (NMDA) receptors, has previously been shown to impair chemoreceptor responsiveness. Studies from this laboratory suggest that fetal reflex ACTH responses to hypotension are largely mediated by chemoreceptors; therefore, we hypothesized that ketamine would inhibit the reflex hormonal response to BCO. Chronically catheterized fetal sheep were subjected to acute cerebral hypoperfusion through occlusion of the brachiocephalic artery. Fetal blood pressure and heart rate were continuously recorded, and fetal blood samples drawn during the experiment were analyzed with specific hormone assays. Our results demonstrate that ketamine attenuates hemodynamic responses to cerebral hypoperfusion and is a potent inhibitor of ACTH and proopiomelanocortin (POMC)/pro-ACTH release. These data support the hypothesis that fetal reflex responses hypotension are chemoreceptor mediated. Given the potency with which ketamine inhibits ACTH response to fetal hypotension, we suggest that the use of ketamine or other anesthetic or analgesic drugs that block or otherwise interact with the NMDA-glutamate pathways, in late pregnancy or in preterm newborns be reconsidered.


Subject(s)
Adrenocorticotropic Hormone/antagonists & inhibitors , Anesthetics, Dissociative/pharmacology , Brain Ischemia/embryology , Hypotension/metabolism , Ketamine/pharmacology , Adrenocorticotropic Hormone/blood , Animals , Blood Pressure/drug effects , Brachiocephalic Trunk , Brain Ischemia/metabolism , Cerebrovascular Circulation , Female , Gestational Age , Heart Rate/drug effects , Hydrocortisone/blood , Hypotension/blood , Hypotension/etiology , Pregnancy , Pressoreceptors/drug effects , Pro-Opiomelanocortin/antagonists & inhibitors , Pro-Opiomelanocortin/blood , Sheep/embryology
2.
Am J Physiol Regul Integr Comp Physiol ; 290(1): R241-50, 2006 Jan.
Article in English | MEDLINE | ID: mdl-16166202

ABSTRACT

Histamine, released from mast cells, can modulate the activity of intrinsic neurons in the guinea pig cardiac plexus. The present study examined the ionic mechanisms underlying the histamine-induced responses in these cells. Histamine evokes a small membrane depolarization and an increase in neuronal excitability. Using intracellular voltage recording from individual intracardiac neurons, we were able to demonstrate that removal of extracellular sodium reduced the membrane depolarization, whereas inhibition of K+ channels by 1 mM Ba2+, 2 mM Cs+, or 5 mM tetraethylammonium had no effect. The depolarization was also not inhibited by either 10 microM Gd3+ or a reduced Cl- solution. The histamine-induced increase in excitability was unaffected by K+ channel inhibitors; however, it was reduced by either blockage of voltage-gated Ca2+ channels with 200 microM Cd2+ or replacement of extracellular Ca2+ with Mg2+. Conversely, alterations in intracellular calcium with thapsigargin or caffeine did not inhibit the histamine-induced effects. However, in cells treated with both thapsigargin and caffeine to deplete internal calcium stores, the histamine-induced increase in excitability was decreased. Treatment with the phospholipase C inhibitor U73122 also prevented both the depolarization and the increase in excitability. From these data, we conclude that histamine, via activation of H1 receptors, activates phospholipase C, which results in 1) the opening of a nonspecific cation channel, such as a transient receptor potential channel 4 or 5; and 2) in combination with either the influx of Ca2+ through voltage-gated channels or the release of internal calcium stores leads to an increase in excitability.


Subject(s)
Heart/innervation , Histamine/pharmacology , Neurons/drug effects , Animals , Calcium/metabolism , Calcium/pharmacology , Estrenes/pharmacology , Female , Guinea Pigs , Male , Neurons/metabolism , Phosphodiesterase Inhibitors/pharmacology , Potassium Channel Blockers/pharmacology , Pyrrolidinones/pharmacology
3.
Physiol Genomics ; 24(3): 218-24, 2006 Feb 14.
Article in English | MEDLINE | ID: mdl-16352695

ABSTRACT

The present study was performed to identify the changes in genomic expression of critical components of the hypothalamus-pituitary-adrenal (HPA) axis in the second half of gestation in fetal sheep. We isolated mRNA from pituitary, hypothalamus, hippocampus, and brain stem in fetal sheep at 80, 100, 120, 130, and 145 days of gestation and 1 and 7 days after delivery (n = 4-5/group). Using real-time RT-PCR, we measured mRNA expression levels of glucocorticoid receptor (GR), mineralocorticoid receptor (MR), serum- and glucocorticoid-induced kinase-1 (sgk1), proopiomelanocortin (POMC), CRF, and arginine vasopressin (AVP). Both MR and GR were highly expressed in pituitary and hippocampus; in all tissues GR was more highly expressed than MR. AVP was more highly expressed than CRF in hypothalamus. MR, GR, and sgk1 expression were increased postnatally in brain stem, and sgk1 expression was increased postnatally in hypothalamus. GR expression was reduced in pituitary in term fetuses compared with younger ages. Hypothalamic CRF expression was increased at the end of gestation compared with younger ages, and AVP expression was increased in newborn lambs. Pituitary POMC was increased at 100 days of gestation compared with 80 days; hypothalamic POMC was increased at 120 days. Overall, the results demonstrate the expression of both MR and GR in brain regions important for control of the HPA axis. Decreases in expression of GR in pituitary at the end of gestation might contribute to the decreased corticosteroid negative feedback sensitivity at term in this species.


Subject(s)
Fetal Development , Fetus/metabolism , Pituitary-Adrenal System/embryology , Adrenal Glands/metabolism , Adrenocorticotropic Hormone/metabolism , Animals , Arginine Vasopressin/genetics , Arginine Vasopressin/metabolism , Brain Stem/metabolism , Corticotropin-Releasing Hormone/genetics , Corticotropin-Releasing Hormone/metabolism , Female , Fetal Development/genetics , Fetus/enzymology , Genetic Markers , Gestational Age , Hippocampus/metabolism , Hydrocortisone/metabolism , Hypothalamus/metabolism , Immediate-Early Proteins/genetics , Immediate-Early Proteins/metabolism , Pituitary Gland/metabolism , Pituitary-Adrenal System/metabolism , Pregnancy , Pro-Opiomelanocortin/genetics , Pro-Opiomelanocortin/metabolism , Protein Serine-Threonine Kinases/genetics , Protein Serine-Threonine Kinases/metabolism , RNA, Messenger/metabolism , Receptors, Glucocorticoid/genetics , Receptors, Glucocorticoid/metabolism , Receptors, Mineralocorticoid/genetics , Receptors, Mineralocorticoid/metabolism , Sheep/embryology , Sheep/metabolism , Species Specificity
SELECTION OF CITATIONS
SEARCH DETAIL
...